Nevro to Report Operating Results for the Third Quarter 2018

REDWOOD CITY, Calif., Oct. 11, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical technology company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it will release financial results for the third quarter of 2018 after market close on Monday, November 5, 2018. Company management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Monday, November 5, 2018.

Investors interested in listening to the conference call may do so by dialing (833) 286-5807 for U.S. callers or (647) 689-4452 for international callers (Conference ID: 3989464), or logging into the webcast on the "Investors" section of the Company's website at www.nevro.com/investors. Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company's website.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza^® System and Senza IItm System are the only SCS systems that deliver Nevro's proprietary HF10^® therapy. Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Investor Relations Contact:
Nevro Investor Relations
(650) 433-3247
[email protected]

SOURCE Nevro Corp.